Third primary COVID-19 vaccine dose for eligible cancer patients

Document first published:
Page updated:
Topic:
,
Publication type:

An update on providing a third primary COVID-19 vaccine dose for all eligible cancer patients, and the next steps to achieve this goal.

National clinical leaders for cancer have advised that most people in this cohort are likely to benefit from receiving a third primary dose as soon as possible.

 

Summary

Letter from Professor Stephen Powis, Dame Cally Palmer and Dr Nikita Kanani.

Published 17 November 2021.